2-Methyl-1-(4-(methylthio)phenyl)-2-morpholinopropan-1-one, 98.0%, 5g

(3-Amino-5-cyanophenyl)boronic acid, 95.0%, 250mg

Lead(II) carbonate, min. 98%, PA, ACS, 500 g, plastic packaging.

trans,trans-4'-Pentyl-4-(3,4,5-trifluorophenyl)bicyclohexyl>98.0%(GC)5g

(2S,3R)-3-Fluoro-2-methylazetidine hydrochloride, 97%, 100mg

1-(Benzenesulfonyl)-6-chloro-pyrrolo[3,2-c]pyridine, 98%, 1g

1-(3-Chloro-5-nitrophenyl)ethan-1-one, 95+%, 250mg

(S)-1-(3,5-Dichlorophenyl)ethanamine hydrochloride, 95.0%, 100mg

ETHYL 2-CHLORO-6H-THIENO[2,3-B]PYRROLE-5-CARBOXYLATE, 95.0%, 250mg

6-Bromo-3-chloropyrazin-2-amine, 95.0%, 25g

5-(Difluoromethyl)-N-[5-({[(2S)-3,3-dimethylbutan-2-yl]amino}methyl)-1-{[(2S)-1-(prop-2-enoyl)pyrrolidin-2-yl]methyl}-1H-1,3-benzodiazol-2-yl]thiophene-2-carboxamide, 98%, 100mg

Methyl 2-aminoisobutyrate hydrochloride, 95.0%, 1g

4-Chloro-5-methyl-6-((2-methylpyridin-3-yl)oxy)pyrimidine, 95.0%, 250mg